Conference Program

DETAILED PROGRAM

TUESDAY 20th MAY 2014

07:30 – 09:00

Registration 

 09:00 – 09:25

Welcome by MIXiii Chairpersons

Yoav Chelouche – Partner, Aviv Venture Capital, Co-Chairman, IATI

Ruti Alon –
General Partner, Pitango Venture Capital

Dr. Benny Zeevi – Managing General Partner, DFJ Tel Aviv Venture
Partners, Co-Chairman, IATI 

Prof. Yesha Sivan – Executive Director, Coller
Institute of Venture at Tel Aviv University 

Avi Hasson –
Chief Scientist of the Ministry of Economy, Israel

 09:25-09:50

H.E. Mme. Liu Yandong, Vice Premier,
State Council, P.R.China

Fireside Chat with The Honorable President of the State of
Israel, Mr. Shimon Peres

09:50-10:15

Interviewer: Mr.
David Rowan – Editor of WIRED magazine, UK Edition 

10:15 – 11:15

Hall A

CEO Panel

Moderator: Yossi Vardi

Michel Combes – Chief Executive Officer, Alcatel Lucent

Weili Dai – President and Co-Founder, Marvell Technology Group

Barry Greene – President & Chief Operating Officer, Alnylam Pharmaceuticals

Charles N. Kahn III – President and Chief Executive Officer, Federation
of American Hospitals

11:15 – 11:45

Coffee Break

11:45 – 12:30

Hall A

Keynote Lecture

Winning in the Age of Revolution
Erez Vigodman, President and Chief Executive Officer, Teva

12:30 – 13:15

Hall A

Keynote Lecture

Health Reform 101 – Its Impact on the USA Healthcare Ecosystem
Charles M. Kahn,
President and Chief Executive Officer, Federation of American Hospitals

13:15 – 14:00

Lunch Break

14:00 – 14:45

Hall A

Keynote Lecture

Current State of the Life Science Capital and Strategic
Markets
Jeffrey Hoffman, Managing Director J.P Morgan

14:45 – 15:45 

Hall A

The Med Tech Makeover:  Beauty Tips from the Big Boys

Moderator: Jonathan Silverstein, General Partner and Co-Head
of Venture Capital, OrbiMed
Chris King, Vice President, Business Development and Strategic Partnering
Cardiac Rhythm Disease Management, Medtronic, Inc.
David Neustaedter, Vice President, Covidien
Ventures
Rafael Torres, Sr. Managing Director & Head of Healthcare, GE Ventures
Brad Vale, PhD, DVM, Head of Johnson & Johnson Development Corporation
(JJDC)
Albert A. Lauritano, MS, CLP, Director, Technology
Licensing & Collaboration, BD Technologies

15:45 – 16:10

Coffee Break

16:10 – 18:30

Hall H

Company Presentations

Hall I

Company Presentations

Hall K

Company Presentations

Hall L

Company Presentations

Hall M

Company Presentations

Hall A

From Translational Research to Deal Making

16:10-17:15

Innovative Funding of Translational Research

Moderator:Amir Naiberg – CEO Yeda
R&D Co. Ltd – Technology Transfer from the Weizmann Institute of Science

Integra Fund:Yaacov Michlin – President & CEO Yissum

T3 Fund:Benjamin Soffer – Manager, Technion
R&D Foundation, Technology Transfer Office 

Momentum Fund:Shlomo Nimrodi – CEO, Ramot
at Tel Aviv University 

Hadasit Fund:Dr. Tamar Raz

Sourasky Hospital: Dr. Michal Roll

17:15-18:30

Deal Making with Academy 

Moderator:Yael Baratz -Senior Partner, Pearl Cohen Zedek Latzer Baratz 

Dr. Mira Peled – CEO of AIT

Prof. Oded Shoseyov – Founder and CSO, Collplant

Louis P. Berneman – Founding Partner, Osage University
Partners

Chaim Lebovits – CEO, Brainstorm

David Malek– VP of Business Development, BiolineRX

Zeev Zehavi– VP, Venture Investments Europe and Israel,
J&J

16:10 – 16:30

Oramed Pharmaceuticals: Overcoming the Challenges of Oral Protein
Delivery

Maxillent Ltd.: A Minimally Invasive Solution for the Sinus Lift
Procedure  

Brainsway Deep TMS –
Breakthrough in Brain Treatment

KAHR Medical LTD: Bifunctional Hexamers of the TNF
ligand Superfamily 

Treato Ltd: The Future of Patient Insights: How Big Data
is Forging New Paths to the Empowered Patient

16:30 – 16:50

Atox Bio: Developing AB103 for Flesh Eating Bacteria

Nephera Ltd.: Protecting the Kidneys in Acute Heart
Failure

ProstaGene: Prostate Cancer- New Diagnostic and Prognostic Tests and New
Treatment for Metastatic Disease

BiondVax Pharmaceuticals Ltd: Pandemic Preparedness Ahead of
Outbreak – BiondVax’s Universal Flu Vaccine

Corbus Pharma:Resunab, a novel Phase II Drug for Life Threatening
Rare Inflammatory Diseases

16:50 – 17:10

ViDAC Pharmaceuticals:Breakthrough Cancer Drugs that Target Cancer
Metabolism 

Leviticus Cardio: Wireless Solution for LVAD
System 

Sight Diagnostics: A Computer Vision Platform for Disease
Diagnosis

MedAware Ltd:Eliminating Prescription Errors: A Systematic Approach

Enzymotec: Mimics the Human Milk Fat – the Way Nature Intended

17:10 – 17:30

TheraCoat: New Hydrogel-Based Drug Delivery System Promises to
Optimize Treatment for Bladder Diseases 

Cardiogard Medical Ltd.:Cerebral Protection During Open Heart Surgery

HeadSense Medical:Non-invasive Intracranial Pressure Monitor

LifeBEAM Technologies Ltd.:  Advanced Bio-sensing Technology,
from Aerospace to Consumer Wearables

OpisoftCare: From Unstructured Clinical Data to Meaningful and
Accessible Insight

17:30 – 17:50

Improdia Ltd.: Innovative Test Kit for Monitoring the
Immune System Status

Wellsense Technologies Ltd.: Continuous Bedside Pressure Mapping –
Improving Patient Care and Financial Outcomes

MobileOCT: Expanding Cervical Cancer Diagnostics to Emerging
Economies

Oggii: Pet Healthcare 

Apos Medical & Sports Technologies: AposTherapy, A Breakthrough
Personalized and Non-Invasive Treatment for Knee & Back Pain

17:50 – 18:10

Tiltan Pharma Ltd.:Developing TL-118 an Oral Anti-angiogenic Treatment
for Cancer

Teva Pharmaceuticals Ltd: Teva Israel:
Collaborate for Better Health 

Medasense Biometrics Ltd.: Medasense
Pain Monitoring Systems – Objective Assessment. Better Results.

Night-Sense: Sweet Dreams for People with Diabetes

Nano Retina

18:10 – 18:30

Peritech Pharma: Novel Drug Delivery Platform

InsuLine Medical:InsuPad – Safe for Targeted Therapy

IMEXCO General Ltd.:Neuro-CPD, a Chronic Pain Detector 

EarlySense:Contact-free Patient Monitoring Solutions

Neuron Guard S.r.l.s

18:30 – 20:30

MIXiii 2014 Gala Event Biomed & Hi-Tech
Hall 1

WEDNESDAY 21st MAY
2014

08:00 – 09:00

Registration 

09:00 – 09:45

Hall A

Keynote Lecture

The Age of 3D Printing
Avi Reichental, CEO, 3D System

09:45  -10:30

Hall A

Keynote Lecture 

The Role of Integrated Technologies in the Innovation of
Medical Practice
Dr. C. Martin Harris, CIO / Chairman, Cleveland Clinic

10:30 – 11:00

Coffee Break

11:00 – 11:45

Hall A

Keynote Lecture

The Purpose of The Medical Device Industry: Solving for
Variability

Dan Wildman, WW President, Ethicon Biosurgery

11:45 – 12:30

Hall A

Keynote Lecture

The Importance of Innovation in a Time of Healthcare
Transformation

Gary L. Gottlieb, M.D, M.B.A President and Chief Executive
Officer Partners Healthcare System, Inc. 

12:30 – 13:30

Lunch Break

13:30 – 14:30

Hall A

The Changing Landscape of Pricing and Reimbursement

Moderator: Barry Greene, President & Chief Operating
Officer, Alnylam Pharmaceuticals
Dr. Kevin Schulman, Professor of Medicine, Duke University School of Medicine
Thomas McCourt, Chief Commercial Officer, Ironwood Pharmaceuticals, Inc.

14:30 – 15:00

Coffee Break

 14:00 – 18:00

Hall E
Connected
Health

14:00-15.30  Connected
Health Stakeholders’ View.

15:30-16:00   Coffee Break

16:00-17:00  Panel Discussion Opportunities and
Challenges of Connected Health

Moderator: Yael Glassman – VP Marketing  & Business
Development, Sensible Medical

Wendy Mayer – Vice President, Worldwide Innovation, Pfizer

Jack Young – Director, Qualcomm Life Fund, Qualcomm Ventures

Bethany Hills – Partner , Epstein Becker & Green

Thierry Zylberberg – Executive Vice
President, Head of Orange Healthcare

Peggy Wang – LongTec China Venture

17:00-18:00  Company Presentations

Essence

HelpAround

MediSafe

Physihome

Telesofia

15:00 – 18:20

Hall H

Company Presentations

Hall I

Company Presentations 

Hall K

Company Presentations

Hall L

Company Presentations

Hall M

Company Presentations

Hall A

15:00 – 16:40

Panel Riding the IPO Wave

Moderator:Chaim Friedland – Partner, Gornitzky
& Co.

Gil Bar Nahum – Managing Director, Jeffries & Co.

Netanel (Natti) Ginor –
Managing Director, Jeffries & Co.

Dvid Tsur – Chief Executive Officer, Kamada
Ltd.

Dr. Yaron Daniely – Chief Executive Officer, Alcobra Ltd.

 Hani Shitrit Bach – Senior Vice President, Tel Aviv
Stock Exchange

Hall A

16:40 – 17:40

Panel Effective and
Efficient Clinical R&D – Taking Advantage of the UK’s Expert Research
Infrastructure

Overview of UK NIHR and R&D Processes of Industry
Engagement

Dr Matthew Hallsworth – Head of External Relations, NOCRI
& Ravi Chana – Business Development Manager, NOCRI

Company Presentations and Panel (Experiences of Israeli
Companies working with NIHR)

Moderator: Dr. Matthew Hallsworth –  Head of External Relations,
NOCRI

Teva – Tami Yardeni, Vice President Global Clinical Operations

Media Cancer Screening – Rami Sharon,  Executive Vice President

NIHR Clinical Research Network – Divya
Chada Manek, Industry Business Development 

EarlySense – Guy Auberbach, Sales Director

15:00 – 15:20

Intec Pharma: Meeting The Unmet Need in Drug Delivery 

Spring Biomed: Spectral Virtual Biopsy Revolutionary
Medical Diagnostics Based on Military Technology for Spectral Imaging 

Fertiprot:Crossing the Barrier for More Efficient Reproduction
and Increased Take-Home Baby Rate

BioZEEN ( Bangalore Biotech Labs Pvt. Ltd.):Efficient bio-pharmaceutical Fermentation
Through Customized, Process Optimized Smart Equipments
and Unique gmp Certified Bio-pilot Laboratory
Training on Best Practices, A Synergistic Dual Recipe for Enhanced Yields

Genome Compiler:CAD for Life

15:20 – 15:40

Compugen:Predictive Discovery of Novel Targeted Medicines

Glusense: Implantable Glucose Monitor

Real Imaging: A Novel Technology for Breast Cancer
Detection and Risk Assessment

NAMSA: Preclinical, Clinical, Regulatory:
NAMSA Gets You to Market Faster

MediWound: Discover Enzymatic Surgery

15:40 – 16:00

Pepticom LTD:Revolutionizing Peptide Drug Discovery 

BioControl Medical: Neurostimulation for the Treatment of Heart Failure

NovellusDx: A New Era in Personalized Medicine

AiM GmbH, Assesment-in-Medicine:Reimbursement Hurdles in the EU and Germany

cCAM Biotherapeutics: First in Class Immunomodulatory mAb to Treat Cancer 

16:00 – 16:20

PolyPid Ltd.:PolyPid – Novel Prolonged And Controlled Drug Delivery Platform

CartiHeal Ltd.: Novel Implant for Cartilage Regeneration

Kadimastem Ltd.: Cellular Theraputics to Treat
Diabetes and ALS

Avalere Health: Reimbursement Experts:Avalere Health

Applied Immune
Technologies (AIT) Ltd: Novel
Therapeutic Recombinant Antibodies Targeting the Intracellular Proteom

16:20 – 16:40

VaxilBio: Superior Antigens for Improved Therapeutic Vaccines and
Antibodies

Pluristem: Cell Therapy – From the Bench to Multi-National Clinical
Studies 

BiolineRX

Sealantis: Alga Mimetic Tissue Adhesives

Silenseed: RNAi-based Medicine – Clinical Evidences from Treatment
of Pancreatic Cancer

16:40 – 17:00

CollPlant Ltd.: Plant Derived rhCollagen
Products for Tissue Repair 

RealView Imaging Ltd.:   Live Interactive 3D Holographic
Imaging, First in Human Experiences

BioCEP Ltd: The CEPir Device for High
Quality Magnetic Cell Separation

Cote Orphan Consulting:FDA Orphan Drug Designation Mini-workshop -Tips
from the Master

Teva Pharmaceuticals Ltd.: The Promise of Personalized Medicine –
Treating the Patient with the Right Drug at the Right Time

17:00 – 17:20

Alcobra: A Clinical-Stage CNS-focused Specialty Biopharmaceutical
Company

KAMADA: Plasma-Derived
Protein Therapeutics for Orphan Indications

Protalix Biotherapeutics:Advances in Clinical Development of the Oral
Treatment for Gaucher and Enzyme Replacement
Therapy for Fabry 

Global
Cardiovascular Innovation Center: The New World in Healthcare Delivery and its Effects on
Innovation – A view from the Cleveland Clinic

Access for Life: Safer, Cheaper Vascular Access

17:20 – 17:40

Azure PCR:  qPCR Analysis: Accurate and
Automatic

PRO-IV Medical: A Mobile Platform for Managing and
Monitoring of Errors During Infusion Therapy

Cell Cure
Neurosciences Ltd.: Fighting
Blindness with a Stem Cell Therapy

Finnegan: New Patenting Techniques For
Attracting Medical Device Investors

IonMed: Cold-Plasma-Based Surgical and Healing Technology

17:40 – 18:00

Quiet Therapeutics:Gagomers – Novel Targeted Nanoclusters for
Therapeutic Intervention in Cancer

Artack Medical: A Quantum Leap in Hernia Mesh Fixation

Prestwick Chemical SAS:Smart Compound Libraries and Smart Hit-Follow-up,
a Powerful Approach to Generate Novelty in Drug Discovery Programs

Marx Biotechnology: Diagnostic Kit for Early Detection of
GVHD – Saving Thousands of Lives Anually

Finnegan: Insider Patenting Tips for Boosting High
Tech Valuation 

18:00 – 18:20

Foamix: Foamix Transforms into a
Specialty Pharmaceutical Company Based On Successful Phase 2 Clinical Trials

 LifeBond Ltd: Surgical Biomaterials
for Improved Patient Care

BioCancell:Bladder Cancer Opportunity

NanoVibronix Ltd.:PainShield Ultrasound Therapy – A Paradigm Shift in
Pain Management

Moebius Medical
Ltd.: A New Concept
in Intra-Articular Therapy for Osteoarthritis

THURSDAY 22nd MAY
2014

08:00 – 09:00

Registration 

09:00 – 10:30

 Hall A

Building Innovation Ecosystems

Chairperson: Avi Hasson, Chief Scientist of the Ministry of
Economy, Israel

Opening Remarks: Mr. Naftali Bennett, Minister of Economy,
Israel 

Overview: Mr Avi Hasson, Chief
Scientist of the Ministry of Economy, Israel 

General Session:

HeuiJae Pahk, President and National CTO,
Office of Strategic R&D Planning, Ministry of Trade, Industry and Energy
Republic of Korea

S. R. Patil, Honorable Minister for Planning, Statistics,
Information Technology, Biotechnology and Science and Technology, Government
of Karnataka

Dr. Mark Shmulevich – Deputy
Minister of Communications, Russia

Maxine Fassberg – Vice President,
Technology and Manufacturing Group, General Manager of Intel Israel

10:30 – 11:00

Coffee Break

11:00 – 11:45

Hall A

Keynote Lecture

Getting Paid for your Products in the US and Europe –
Medical Device, Pharma and HealthIT

Susan W. Berson, Managing Member, Mintz Levin

11:45 – 12:30

Hall A

Keynote Lecture

Frontiers in the Development, Manufacture and Use of New
Therapies

Kieran Murphy, President and CEO, GE Health Care, Life
Sciences Division

12:30 – 13:30

Lunch Break

13:30 – 14:15

Hall A

Keynote Lecture

New Era in Pharma: Pertinent Issues and Their Implications for
Pharmaceutical Companies and Business Development

Sophie Kornowski – Bonnet, Head of Roche Partnering Roche 

14:15-14:55

 Hall H

Company Presentations

Hall I

Company Presentations

Hall K

Company Presentations

Hall L

Company Presentations

Hall M

Company Presentation

14:15-14:35

Tonix Pharmaceuticals Corp.(TNXP): Is Sleep Disturbance an Achilles Heel of the
Fibromyalgia and PTSD Monsters?

StarletDerma: A Natural, Marine Extracted Micro-Injuction
Delivery Platform 

Solubest:Capitalizing on Proprietary Platforms for Drug
Re-profiling 

 Quasar: CGMP
Compatible Production in China – From Dream to Reality

Trendlines:Pitfalls of Medical Technology Investments

14:35-14:55

Immune Phamaceuticals:Personalized Medicine and Targeted Therapies for Better
Outcomes

Aposense: From Depot To Target, Enhancing Effectiveness And Safety Of
Known Drugs

CoreBone: Bioactive Coral Bone Graft

EcoFusion:Rapid Self Change Using Wearables

14:55-15:30

Coffee Break

15:30-17:00

WOW Biomed
Competition

17:00-18:00

MIXiii Start-up Awards and Reflection

Biomed: Dr.
Irit Yaniv & Dr.
Benny Zeevi, Managing General Partner, DFJ Tel Aviv Venture Partners,
Co-Chairman, IATI 

Hi-Tech: David
Stark, OurCrowd & Prof. Yesha Sivan,
Executive Director, Coller Institute of Venture at
Tel Aviv University